B.S., M.S., or equivalent experience in computer science or bioinformatics. You would develop or deepen your understanding of bioinformatics, the drug discovery...
From NIBR - Fri, 31 Mar 2017 15:39:15 GMT - View all Cambridge jobs

General laboratory methods, such as filtration, centrifugation, bio-separations, spectroscopy, light microscopy and image analysis....
From Nanotherapeutics, Inc - Fri, 31 Mar 2017 15:20:41 GMT - View all Alachua jobs

Not Specified: Celgene: DescriptionCelgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health.  We value San Diego, California (US)

The successful applicant is expected to play a key scientific role leveraging innovative computational analysis strategies across a variety of biological and...
From Celgene Corporation - Fri, 31 Mar 2017 10:14:57 GMT - View all San Diego jobs

Analyze and model structured data and implement algorithms to support analysis using advanced statistical and mathematical methods from statistics, machine...
From KPMG LLP - Fri, 31 Mar 2017 08:29:58 GMT - View all Atlanta jobs

Notice NOT-HL-17-501 from the NIH Guide for Grants and Contracts

(1) a CV, (2) a Brief Statement of Research Interest and Relevant Background, (3) the Names and Contact Information for Three References, and (4) Two Sample...
From Cold Spring Harbor Laboratory - Fri, 31 Mar 2017 05:31:10 GMT - View all Cold Spring Harbor jobs

Writing Python code for bioinformatics analysis. Our current interests include single-cell and metagenomic analysis....
From Illumina, Inc. - Fri, 31 Mar 2017 00:29:46 GMT - View all San Francisco jobs

Bioinformatics – knowledge of genomic and proteomic databases for analysis. (a) analysis of performers’ technical deliverables and publications;...
From SAIC - Thu, 30 Mar 2017 21:11:10 GMT - View all College Park jobs

Scientists are on the cusp of delivering on that potential, but it is going to take more and easier to use data and computational power to bring clarity and...
From Microsoft - Thu, 30 Mar 2017 21:09:03 GMT - View all Redmond jobs

In addition, please submit a CV and References to Dr. A Blue Gene/L and 3 racks of Linux GPU supercomputers for computational biology and bioinformatics;...
From University of Minnesota - Thu, 30 Mar 2017 19:15:16 GMT - View all Minnesota jobs

Funding Opportunity PA-17-241 from the NIH Guide for Grants and Contracts. The National Cancer Institute (NCI) is committed to reducing cancer related health disparities that affect all health disparity and underserved populations in the United States and to supporting research education, training and capacity building within, and near these communities. The NCI established the Center to Reduce Cancer Health Disparities (CRCHD) to strengthen cancer research by: addressing cancer health disparities; advising on strategic priorities, program direction, and scientific policy to strengthen cancer disparities research and training; and leading NCIs efforts to enhance scientific workforce diversity through the training of students and investigators from underrepresented backgrounds.

Funding Opportunity PA-17-239 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages applications that propose to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate the genetic architecture of cancer risk and related outcomes. The goal of this initiative is to address key scientific questions relevant to cancer epidemiology by supporting the analysis of existing genetic or genomic datasets, possibly in combination with environmental, outcomes, behavioral, lifestyle, and molecular profiles data. Applications to this FOA are encouraged to leverage existing genetic data and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.

Funding Opportunity PA-17-243 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages applications that propose to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate the genetic architecture of cancer risk and related outcomes. The goal of this initiative is to address key scientific questions relevant to cancer epidemiology by supporting the analysis of existing genetic or genomic datasets, possibly in combination with environmental, outcomes, behavioral, lifestyle, and molecular profiles data. Applications to this FOA are encouraged to leverage existing genetic data and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.

Funding Opportunity PAR-17-240 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for the development of innovative research projects in cancer nanotechnology. This initiative, to be known as Innovative Research in Cancer Nanotechnology (IRCN), is a component of a broader program that is the NCI Alliance for Nanotechnology in Cancer. IRCN awards are designed to enable multidisciplinary research and transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposed projects should address major barriers in cancer biology and/or oncology using nanotechnology and should emphasize fundamental understanding of nanomaterial and/or nanodevice interactions with biological systems. This scope includes research concerning the delivery of nanoparticles and/or nanodevices to desired and intended cancer targets in vivo and/or characterization of in vitro detection and diagnostic devices.

Funding Opportunity RFA-NS-17-010 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to invite applications to continue support of a national program of mentored research career development for junior neurosurgeon faculty at institutions nationwide that support neurosurgical research. The goal of the program is to expand the cadre of neurosurgeon investigators trained to conduct research into neurological disorders, making use of their neurosurgical training.

Negotiable: Paramount Recruitment: Associate Director - Genomics - CardioVascular/Metabolic - Germany One of the top leading Pharmaceutical companies in the world has an opening for an Associate Director in their renowned Bioinformatics department. Biberach an der Riß, Germany

Funding Opportunity RFA-HL-18-014 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to establish up to four Centers for the Investigation of Factor VIII immunogenicity (FVIII Centers). These Centers will utilize cross-disciplinary science and novel technologies to define the basic mechanisms involved in the development of anti-FVIII neutralizing antibodies, also known as FVIII inhibitors, in patients with congenital hemophilia A.

Funding Opportunity PAR-17-237 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for the Centers for AIDS Research (CFAR) program to provide administrative and shared research support to enhance HIV/AIDS research. CFARs provide core facilities, expertise, resources, and services not readily obtained otherwise through more traditional funding mechanisms. The program emphasizes interdisciplinary collaboration across all areas of HIV/AIDS research.

Funding Opportunity PAR-17-238 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for the Developmental Centers for AIDS Research (D-CFAR) program to provide administrative and shared research support to enhance HIV/AIDS research. D-CFARs provide core facilities, expertise, resources, and services not readily obtained otherwise through more traditional funding mechanisms. Additionally, D-CFARs provide support to assist investigators in the development of a competitive standard CFAR. The program emphasizes interdisciplinary collaboration across all areas of HIV/AIDS research.